Literature DB >> 1505960

The genes for MHC class II regulatory factors RFX1 and RFX2 are located on the short arm of chromosome 19.

L Pugliatti1, J Derré, R Berger, C Ucla, W Reith, B Mach.   

Abstract

RFX1 is a transacting DNA-binding regulatory factor involved in the control of MHC class II gene expression. RFX2 is a structurally very similar protein with identical DNA binding features. A member of the family of RFX factors is affected in an autosomal recessive disease, MHC class II deficient combined immunodeficiency (CID), caused by a defect in a trans-acting regulatory factor controlling MHC class II gene expression. In situ hybridization with 3H-labeled RFX1 cDNA has allowed us to identify two distinct targets on the short arm of chromosome 19 (19p13.1 and 19p13.2-p13.3). With the use of biotinylated genomic cosmid clones specific for RFX1 and RFX2, respectively, it was then possible to localize RFX1 at 19p13.1 and RFX2 at 19p13.2-p13.3. These two regulatory genes are thus assigned to a region of high gene density and RFX1 is close to another DNA-binding factor, LYL1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505960     DOI: 10.1016/0888-7543(92)90052-t

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  5 in total

1.  Unbiased discovery of interactions at a control locus driving expression of the cancer-specific therapeutic and diagnostic target, mesothelin.

Authors:  Yunzhao R Ren; Raghothama Chaerkady; Shaohui Hu; Jun Wan; Jiang Qian; Heng Zhu; Akhilesh Pandey; Scott E Kern
Journal:  J Proteome Res       Date:  2012-10-12       Impact factor: 4.466

2.  The major histocompatibility complex class II promoter-binding protein RFX (NF-X) is a methylated DNA-binding protein.

Authors:  X Y Zhang; N Jabrane-Ferrat; C K Asiedu; S Samac; B M Peterlin; M Ehrlich
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

3.  iDREM: Interactive visualization of dynamic regulatory networks.

Authors:  Jun Ding; James S Hagood; Namasivayam Ambalavanan; Naftali Kaminski; Ziv Bar-Joseph
Journal:  PLoS Comput Biol       Date:  2018-03-14       Impact factor: 4.475

Review 4.  RFX1: a promising therapeutic arsenal against cancer.

Authors:  Joby Issac; Pooja S Raveendran; Ani V Das
Journal:  Cancer Cell Int       Date:  2021-05-08       Impact factor: 5.722

5.  Nintedanib induces gene expression changes in the lung of induced-rheumatoid arthritis-associated interstitial lung disease mice.

Authors:  Shintaro Mikami; Yoko Miura; Shinji Kondo; Kosuke Sakai; Hiroaki Nishimura; Hiroyuki Kyoyama; Gaku Moriyama; Nobuyuki Koyama; Hideki Noguchi; Hirotsugu Ohkubo; Satoshi Kanazawa; Kazutsugu Uematsu
Journal:  PLoS One       Date:  2022-06-17       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.